Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation
Citation
Nelson, W. W., Wang, L., Baser, O., Damaraju, C. V., & Schein, J. R. (January 01, 2015). Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation. Journal of Medical Economics, 18, 5, 333-340.Abstract
Patients with out-of-range international normalized ratio (INR) values <2.0 and >3.0 have been associated with increased risk of thromboembolic and bleeding events. INR monitoring is costly, because of associated physician and nurse time, laboratory resource use, and dose adjustments.
